Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 1
1990 1
1991 1
1992 1
1993 4
1994 10
1995 5
1996 11
1997 15
1998 10
1999 8
2000 12
2001 8
2002 9
2003 8
2004 10
2005 19
2006 12
2007 16
2008 13
2009 10
2010 4
2011 6
2012 7
2013 3
2014 6
2015 2
2016 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Results by year
Filters applied: . Clear all
Page 1
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.
Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D. Geyer CE, et al. Among authors: skarlos d. N Engl J Med. 2006 Dec 28;355(26):2733-43. doi: 10.1056/NEJMoa064320. N Engl J Med. 2006. PMID: 17192538 Free article. Clinical Trial.
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.
Rossi A, Di Maio M, Chiodini P, Rudd RM, Okamoto H, Skarlos DV, Früh M, Qian W, Tamura T, Samantas E, Shibata T, Perrone F, Gallo C, Gridelli C, Martelli O, Lee SM. Rossi A, et al. Among authors: skarlos dv. J Clin Oncol. 2012 May 10;30(14):1692-8. doi: 10.1200/JCO.2011.40.4905. Epub 2012 Apr 2. J Clin Oncol. 2012. PMID: 22473169 Review.
Treatment of small cell lung cancer.
Christodoulou C, Skarlos DV. Christodoulou C, et al. Among authors: skarlos dv. Semin Respir Crit Care Med. 2005 Jun;26(3):333-41. doi: 10.1055/s-2005-871992. Semin Respir Crit Care Med. 2005. PMID: 16052435 Review.
Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis.
De Ruysscher D, Lueza B, Le Péchoux C, Johnson DH, O'Brien M, Murray N, Spiro S, Wang X, Takada M, Lebeau B, Blackstock W, Skarlos D, Baas P, Choy H, Price A, Seymour L, Arriagada R, Pignon JP; RTT-SCLC Collaborative Group. De Ruysscher D, et al. Among authors: skarlos d. Ann Oncol. 2016 Oct;27(10):1818-28. doi: 10.1093/annonc/mdw263. Epub 2016 Jul 19. Ann Oncol. 2016. PMID: 27436850 Free PMC article. Review.
Tooth and consequences.
Melakopoulos I, Karageorgopoulos DE, Christodoulou C, Skarlos DV, Falagas ME. Melakopoulos I, et al. Among authors: skarlos dv. Am J Med. 2008 Jul;121(7):577-9. doi: 10.1016/j.amjmed.2007.12.001. Am J Med. 2008. PMID: 18589052 No abstract available.
Can cetuximab affect paraneoplastic myopathy?
Galani E, Bonakis A, Christodoulou C, Klouvas G, Drougou A, Skarlos D. Galani E, et al. Among authors: skarlos d. J Neurooncol. 2009 Jul;93(3):437-8. doi: 10.1007/s11060-009-9795-6. Epub 2009 Jan 22. J Neurooncol. 2009. PMID: 19159079
Response of malignant thymoma to erlotinib.
Christodoulou C, Murray S, Dahabreh J, Petraki K, Nikolakopoulou A, Mavri A, Skarlos D. Christodoulou C, et al. Among authors: skarlos d. Ann Oncol. 2008 Jul;19(7):1361-1362. doi: 10.1093/annonc/mdn388. Epub 2008 Jun 4. Ann Oncol. 2008. PMID: 18534960 Free article. No abstract available.
196 results